264 related articles for article (PubMed ID: 34406042)
1. Increasing Gene Editing Efficiency for CRISPR-Cas9 by Small RNAs in Pluripotent Stem Cells.
Shahryari A; Moya N; Siehler J; Wang X; Burtscher I; Lickert H
CRISPR J; 2021 Aug; 4(4):491-501. PubMed ID: 34406042
[TBL] [Abstract][Full Text] [Related]
2. Highly efficient genome editing via CRISPR-Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression.
Li XL; Li GH; Fu J; Fu YW; Zhang L; Chen W; Arakaki C; Zhang JP; Wen W; Zhao M; Chen WV; Botimer GD; Baylink D; Aranda L; Choi H; Bechar R; Talbot P; Sun CK; Cheng T; Zhang XB
Nucleic Acids Res; 2018 Nov; 46(19):10195-10215. PubMed ID: 30239926
[TBL] [Abstract][Full Text] [Related]
3. Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks.
Yang H; Ren S; Yu S; Pan H; Li T; Ge S; Zhang J; Xia N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899704
[TBL] [Abstract][Full Text] [Related]
4. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair.
He X; Tan C; Wang F; Wang Y; Zhou R; Cui D; You W; Zhao H; Ren J; Feng B
Nucleic Acids Res; 2016 May; 44(9):e85. PubMed ID: 26850641
[TBL] [Abstract][Full Text] [Related]
5. Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation.
Xu X; Gao D; Wang P; Chen J; Ruan J; Xu J; Xia X
Sci Rep; 2018 Aug; 8(1):11649. PubMed ID: 30076383
[TBL] [Abstract][Full Text] [Related]
6. Baculovirus-based genome editing in primary cells.
Mansouri M; Ehsaei Z; Taylor V; Berger P
Plasmid; 2017 Mar; 90():5-9. PubMed ID: 28119062
[TBL] [Abstract][Full Text] [Related]
7. Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases.
Yang D; Scavuzzo MA; Chmielowiec J; Sharp R; Bajic A; Borowiak M
Sci Rep; 2016 Feb; 6():21264. PubMed ID: 26887909
[TBL] [Abstract][Full Text] [Related]
8. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
[TBL] [Abstract][Full Text] [Related]
9. Precision genome editing in the CRISPR era.
Salsman J; Dellaire G
Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
[TBL] [Abstract][Full Text] [Related]
10. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
Albadri S; Del Bene F; Revenu C
Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR-Cas9 genome editing.
Paulsen BS; Mandal PK; Frock RL; Boyraz B; Yadav R; Upadhyayula S; Gutierrez-Martinez P; Ebina W; Fasth A; Kirchhausen T; Talkowski ME; Agarwal S; Alt FW; Rossi DJ
Nat Biomed Eng; 2017 Nov; 1(11):878-888. PubMed ID: 31015609
[TBL] [Abstract][Full Text] [Related]
12. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Bloomer H; Smith RH; Hakami W; Larochelle A
Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
[TBL] [Abstract][Full Text] [Related]
13. Correction of Hemoglobin E/Beta-Thalassemia Patient-Derived iPSCs Using CRISPR/Cas9.
Wattanapanitch M
Methods Mol Biol; 2021; 2211():193-211. PubMed ID: 33336279
[TBL] [Abstract][Full Text] [Related]
14. Efficient and allele-specific genome editing of disease loci in human iPSCs.
Smith C; Abalde-Atristain L; He C; Brodsky BR; Braunstein EM; Chaudhari P; Jang YY; Cheng L; Ye Z
Mol Ther; 2015 Mar; 23(3):570-7. PubMed ID: 25418680
[TBL] [Abstract][Full Text] [Related]
15. Rates of homology directed repair of CRISPR-Cas9 induced double strand breaks are lower in naïve compared to primed human pluripotent stem cells.
Dodsworth BT; Hatje K; Meyer CA; Flynn R; Cowley SA
Stem Cell Res; 2020 Jul; 46():101852. PubMed ID: 32521498
[TBL] [Abstract][Full Text] [Related]
16. A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells.
Jurlina SL; Jones MK; Agarwal D; De La Toba DV; Kambli N; Su F; Martin HM; Anderson R; Wong RM; Seid J; Attaluri SV; Chow M; Wahlin KJ
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553630
[TBL] [Abstract][Full Text] [Related]
17. Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing.
Tatiossian KJ; Clark RDE; Huang C; Thornton ME; Grubbs BH; Cannon PM
Mol Ther; 2021 Mar; 29(3):1057-1069. PubMed ID: 33160457
[TBL] [Abstract][Full Text] [Related]
18. Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing.
Miyaoka Y; Berman JR; Cooper SB; Mayerl SJ; Chan AH; Zhang B; Karlin-Neumann GA; Conklin BR
Sci Rep; 2016 Mar; 6():23549. PubMed ID: 27030102
[TBL] [Abstract][Full Text] [Related]
19. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
20. A high-efficiency and versatile CRISPR/Cas9-mediated HDR-based biallelic editing system.
Li X; Sun B; Qian H; Ma J; Paolino M; Zhang Z
J Zhejiang Univ Sci B; 2022 Feb; 23(2):141-152. PubMed ID: 35187887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
